Decreased lung function or resultant pulmonary hypertension correlates with endothelial dysfunction and increased levels of inflammatory mediators, such as C-reactive protein, interleukin-6, interleukin-8, and tumor necrosis factor-alpha (33–35). The gene discussed is IL6; the disease is pulmonary arterial hypertension.